MétaCan
Menu
← Back to cohort

Chronic AMPK activation reduces synaptic plasticity markers in Neuronal SH‐SY5Y Cells

2021· article· en· W3170195393 on OpenAlexaff
Alex Yang, Litsa Tsiani, Aleksander Necakov, Rebecca E. K. MacPherson

Bibliographic record

VenueThe FASEB Journal · 2021
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicMetabolism, Diabetes, and Cancer
Canadian institutionsBrock University
Fundersnot available
KeywordsAMPKmTORC1SynaptophysinAMP-activated protein kinaseProtein kinase ANeurogenesisCell biologyBiologyChemistryEndocrinologySignal transductionKinasePI3K/AKT/mTOR pathwayImmunology

Abstract

fetched live from OpenAlex

Neuronal synapse function and growth rely on the abundance proteins at the synapse. This abundance is regulated by key metabolic markers: AMP‐Kinase (AMPK) and the Mechanistic Target of Rapamycin Complex 1 (mTORC1). AMPK is a serine/threonine kinase highly expressed in brain. When activated, AMPK stimulates catabolic processes, and inhibits anabolic processes through mTORC1 inhibition. Defects in AMPK signaling have been reported in peripheral metabolic disorders and the manipulation of AMPK activity has been an attractive therapeutic target for diseases in which altered energy metabolism contributes to etiology (Obesity type‐2‐diabetes). Recent evidence also suggests that impaired AMPK activity plays a role in Alzheimer's disease. However, there is ambiguity surrounding the role of AMPK activation in neuronal metabolic regulation and its affects on neuron growth and health. The objective of this study was to determine the direct effect of chronic AMPK modulation on markers related to synapse growth and function in a neuronal cell culture model. Retinoic acid differentiated (1g/mL) SH‐SY5Y Human Neuroblastoma cells were treated with: 1) Vehicle control; 2) A‐769662 (100uM; AMPK agonist); or 3) compound C (30uM; AMPK inhibitor). Cells were treated for 1, 3, and 5 days to examine chronic AMPK activation or inhibition. Cell lysates were collected for western blotting (WB) to examine AMPK activation (AMPK T172), a marker of mTORC1 formation and cellular proliferation (raptor), and markers of neurogenesis and pre/post‐synaptic proteins (synaptophysin, homer‐1, PSD‐95, synaptophysin, BDNF). PSD‐95, homer‐1, synaptophysin, and BDNF are significant markers in maintaining/developing proper synapse function and strength. AMPK T172 phosphorylation following treatment with A‐769662, was higher than control for all time points (24h, 3d, 5d) and resulted in higher raptor S792 phosphorylation compared to control, indicative of chronic mTORC1 inhibition. No changes in neuronal marker content was observed following 24h of AMPK activation. However, significant reductions were seen in PSD‐95, homer‐1, synaptophysin, and BDNF content following 3d and 5d of AMPK activation. Taken together, these findings indicate a role for AMPK activation in regulating key synaptic plasticity markers and highlights drawbacks in pursuing AMPK as a therapeutic target for metabolic diseases such as Alzheimer's disease.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.229
Teacher spread0.219 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueThe FASEB Journal→Same topicMetabolism, Diabetes, and Cancer→French-language works237,207→